Teachers Advisors’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History

Teachers Advisors’s Portfolio VIRX Stock Details VIRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-360	Closed	-$185K	–	3132
2015 Q1	$185K	Buy	360 +32	+10%	+$16.1K	﹤0.01%	2910
2014 Q4	$175K	Hold	328	–	–	﹤0.01%	2947
2014 Q3	$491K	Hold	328	–	–	﹤0.01%	2412
2014 Q2	$448K	Buy	328 +99	+43%	+$115K	﹤0.01%	2496
2014 Q1	$318K	Hold	229	–	–	﹤0.01%	2647
2013 Q4	$228K	Hold	229	–	–	﹤0.01%	2803
2013 Q3	$239K	Buy	229 +20	+10%	+$21.4K	﹤0.01%	2733
2013 Q2	$229K	Buy	+209	New	+$233K	﹤0.01%	2683

Other funds holding VIRX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Teachers Advisors's VIRX Position: Q2 2015 in Review

Teachers Advisors sold out of Viracta Therapeutics, Inc. Common Stock (VIRX) in Q2 2015, closing a stake of 360 shares — an estimated $185K sold.

Teachers Advisors first reported a position in VIRX in Q2 2013 and held it in 8 quarters. The position peaked at $491K in Q3 2014. 80 funds tracked by Wall St. Rank hold VIRX as of Q2 2015.

Teachers Advisors reported no remaining Viracta Therapeutics, Inc. Common Stock position as of Q2 2015 after selling out during the quarter.
Teachers Advisors sold 360 Viracta Therapeutics, Inc. Common Stock shares in Q2 2015, an estimated $185K.
Teachers Advisors first reported a position in Viracta Therapeutics, Inc. Common Stock in Q2 2013 and held it in 8 quarters.
Teachers Advisors's Viracta Therapeutics, Inc. Common Stock position peaked at $491K in Q3 2014.
80 funds tracked by Wall St. Rank held Viracta Therapeutics, Inc. Common Stock as of Q2 2015.

Based on Teachers Advisors's 13F filing for Q2 2015, filed 10 Aug 2015.